nach oben

Erschienen in:

01.09.2008 | Biological Psychiatry - Original Article

Association between polymorphisms in the vesicle-associated membrane protein-associated protein A (VAPA) gene on chromosome 18p and bipolar disorder

verfasst von: Falk W. Lohoff, Andrew E. Weller, Paul J. Bloch, Aleksandra H. Nall, Thomas N. Ferraro, Wade H. Berrettini

Erschienen in: Journal of Neural Transmission | Ausgabe 9/2008

Einloggen, um Zugang zu erhalten

Abstract

Linkage studies in bipolar disorder (BPD) suggest that a susceptibility locus exists on chromosome 18p11. The vesicle-associated membrane protein-associated protein A (VAPA) gene maps to this region. VAPA interacts with presynaptic proteins and is necessary for vesicular neurotransmission. Dysregulation of synaptic neurotransmission might contribute to the pathophysiology of BPD. In this study, we hypothesize that genetic variations in the VAPA gene contribute to BPD. We tested this hypothesis by genotyping 6 SNPs (rs494015; rs29193; rs29162; rs29145; rs29067; rs29066) in BPD patients (n = 570) and healthy controls (n = 730). Genotype and allele frequencies were compared between groups using Chi square contingency analysis. Linkage disequilibrium (LD) between markers was calculated and estimated haplotype frequencies were compared between groups. Single marker analysis revealed an association of rs29067 and rs29066 with BPD; however, after permutation correction, only rs29066 showed a trend towards an allelic association (P = 0.066). Haplotype analysis did not show any significant association with disease after permutation correction. Our results provide suggestive evidence of an association between SNPs in the 3′UTR of the VAPA gene and BPD. Interestingly, these SNPs are in close proximity to the microsatellite marker D18S464, which showed significant signals in previous linkage studies of BPD. Additional studies are necessary to confirm and elucidate the role of VAPA as a susceptibility gene for BPD on chromosome 18p.

Bacanu SA, Devlin B, Roeder K (2000) The power of genomic control. Am J Hum Genet 66:1933–1944PubMedCrossRef

Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265PubMedCrossRef

Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, Schulze TG, Cichon S, Rietschel M, Nothen MM, Georgi A, Schumacher J, Schwarz M, Abou Jamra R, Hofels S, Propping P, Satagopan J, Detera-Wadleigh SD, Hardy J, McMahon FJ (2008) A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 13:197–207PubMedCrossRef

Beasley CL, Honer WG, Bergmann K, Falkai P, Lutjohann D, Bayer TA (2005) Reductions in cholesterol and synaptic markers in association cortex in mood disorders. Bipolar Disord 7:449–455PubMedCrossRef

Bennett P, Segurado R, Jones I, Bort S, McCandless F, Lambert D, Heron J, Comerford C, Middle F, Corvin A, Pelios G, Kirov G, Larsen B, Mulcahy T, Williams N, O’Connell R, O’Mahony E, Payne A, Owen M, Holmans P, Craddock N, Gill M (2002) The wellcome trust UK-Irish bipolar affective disorder sibling-pair genome screen: first stage report. Mol Psychiatry 7:189–200PubMedCrossRef

Berrettini WH, Ferraro TN, Goldin LR, Weeks DE, Detera-Wadleigh S, Nurnberger JI Jr, Gershon ES (1994) Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene. Proc Natl Acad Sci USA 91:5918–5921PubMedCrossRef

Berrettini WH, Vuoristo J, Ferraro TN, Buono RJ, Wildenauer D, Ala-Kokko L (1998) Human G(olf) gene polymorphisms and vulnerability to bipolar disorder. Psychiatr Genet 8:235–238PubMedCrossRef

Bly M (2005) Mutation in the vesicular monoamine gene, SLC18A1, associated with schizophrenia. Schizophr Res 78:337–338PubMedCrossRef

Bowen T, Kirov G, Gill M, Spurlock G, Vallada HP, Murray RM, McGuffin P, Collier DA, Owen MJ, Craddock N (1999) Linkage studies of bipolar disorder with chromosome 18 markers. Am J Med Genet 88:503–509PubMedCrossRef

Chen K, Rajewsky N (2006) Natural selection on human microRNA binding sites inferred from SNP data. Nat Genet 38:1452–1456PubMedCrossRef

Chen SF, Chen CH, Chen JY, Wang YC, Lai IC, Liou YJ, Liao DL (2007) Support for association of the A277C single nucleotide polymorphism in human vesicular monoamine transporter 1 gene with schizophrenia. Schizophr Res 90:363–365PubMedCrossRef

Corradi JP, Ravyn V, Robbins AK, Hagan KW, Peters MF, Bostwick R, Buono RJ, Berrettini WH, Furlong ST (2005) Alternative transcripts and evidence of imprinting of GNAL on 18p11.2. Mol Psychiatry 10:1017–1025PubMedCrossRef

Detera-Wadleigh SD, Badner JA, Berrettini WH, Yoshikawa T, Goldin LR, Turner G, Rollins DY, Moses T, Sanders AR, Karkera JD, Esterling LE, Zeng J, Ferraro TN, Guroff JJ, Kazuba D, Maxwell ME, Nurnberger JI Jr, Gershon ES (1999) A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc Natl Acad Sci USA 96:5604–5609PubMedCrossRef

Devlin B, Roeder K (1999) Genomic control for association studies. Biometrics 55:997–1004PubMedCrossRef

Eastwood SL, Harrison PJ (2000) Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs. Mol Psychiatry 5:425–432PubMedCrossRef

Esterling LE, Cox Matise T, Sanders AR, Yoshikawa T, Overhauser J, Gershon ES, Moskowitz MT, Detera-Wadleigh SD (1997) An integrated physical map of 18p11.2: a susceptibility region for bipolar disorder. Mol Psychiatry 2:501–504PubMedCrossRef

Fatemi SH, Earle JA, Stary JM, Lee S, Sedgewick J (2001) Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia. Neuroreport 12:3257–3262PubMedCrossRef

Frayling TM (2007) Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 8:657–662PubMedCrossRef

Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, Patterson N, Gabriel SB, Topol EJ, Smoller JW, Pato CN, Pato MT, Petryshen TL, Kolonel LN, Lander ES, Sklar P, Henderson B, Hirschhorn JN, Altshuler D (2004) Assessing the impact of population stratification on genetic association studies. Nat Genet 36:388–393PubMedCrossRef

Gutiérrez B, Rosa A, Papiol S, Arrufat F, Catalán R, Salgado P, Peralta V, Cuesta M, Fañanás L (2007) Identification of two risk haplotypes for schizophrenia and bipolar disorder in the synaptic vesicle monoamine transporter gene (SVMT). Am J Med Genet B Neuropsychiatr Genet 144B:502–507PubMedCrossRef

Heslop KE, Curzon G (1999) Effect of reserpine on behavioural responses to agonists at 5-HT1A, 5-HT1B, 5-HT2A, and 5-HT2C receptor subtypes. Neuropharmacology 38:883–891PubMedCrossRef

Hieronymus H, Silver PA (2004) A systems view of mRNP biology. Genes Dev 18:2845–2860PubMedCrossRef

Hirschfeld RM (2000) History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry 61 Suppl 6:4–6PubMed

Honer WG, Falkai P, Bayer TA, Xie J, Hu L, Li H-Y, Arango V, Mann JJ, Dwork AJ, Trimble WS (2002) Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. Cereb Cortex 12:349–356PubMedCrossRef

Ilardi JM, Mochida S, Sheng Z-H (1999) Snapin: a SNARE-associated protein implicated in synaptic transmission. Nat Neurosci 2:119–124

Ishiguro H, Ohtsuki T, Okubo Y, Kurumaji A, Arinami T (2001) Association analysis of the pituitary adenyl cyclase activating peptide gene (PACAP) on chromosome 18p11 with schizophrenia and bipolar disorders. J Neural Transm 108:849–854PubMedCrossRef

Jayanthi LD, Ramamoorthy S (2005) Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants. Aaps J 7:E728–E738PubMedCrossRef

John I Nurnberger JRD Jr, Gershon Elliot S, Reich Theodore, Blehar Mary C, Edenberg Howard J, Foroud Tatiana, Miller Marvin, Bowman Elizabeth, Aimee Mayeda N, Rau Leela, Carrie Smiley P, Conneally Michael, McMahon Francis, Meyers Deborah, Simpson Sylvia, Melvin McInnis O, Stine Colin, Detera-Wadleigh Sevilla, Goldin Lynn, Guroff Juliet, Maxwell Elizabeth, Kazuba Diane, Gejman Pablo V, Badner Judith, Sanders Alan, Rice John, Bierut Laura, Goate Alison (1997) Genomic survey of bipolar illness in the NIMH genetics initiative pedigrees: a preliminary report. Am J Med Genet 74:227–237

Kessler RC, Andrews G, Mroczek D, Ustun B, Wittchen H (1998) The World Health Organization composite international diagnostic interview short-form (CIDI-SF). Int J Methods Psychiatr Res 7:171–185CrossRef

Lohoff FW, Berrettini WH (2005) Lack of association between variations in the melanocortin 5 receptor gene and bipolar disorder. Psychiatr Genet 15:255–258PubMedCrossRef

Lohoff FW, Dahl JP, Ferraro TN, Arnold SE, Gallinat J, Sander T, Berrettini WH (2006) Variations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar I disorder. Neuropsychopharmacology 31:2739–2747PubMedCrossRef

McInnes LA, Escamilla MA, Service SK, Reus VI, Leon P, Silva S, Rojas E, Spesny M, Baharloo S, Blankenship K, Peterson A, Tyler D, Shimayoshi N, Tobey C, Batki S, Vinogradov S, Meza L, Gallegos A, Fournier E, Smith LB, Barondes SH, Sandkuijl LA, Freimer NB (1996) A complete genome screen for genes predisposing to severe bipolar disorder in two Costa Rican pedigrees. Proc Natl Acad Sci USA 93:13060–13065PubMedCrossRef

Mukherjee O, Meera P, Ghosh S, Kubendran S, Kiran K, Manjunath KR, Subhash MN, Benegal V, Brahmachari SK, Majumder PP, Jain S (2006) Evidence of linkage and association on 18p11.2 for psychosis. Am J Med Genet B Neuropsychiatr Genet 141B:868–873PubMedCrossRef

Nothen MM, Cichon S, Rohleder H, Hemmer S, Franzek E, Fritze J, Albus M, Borrmann-Hassenbach M, Kreiner R, Weigelt B, Minges J, Lichtermann D, Maier W, Craddock N, Fimmers R, Holler T, Baur MP, Rietschel M, Propping P (1999) Evaluation of linkage of bipolar affective disorder to chromosome 18 in a sample of 57 German families. Mol Psychiatry 4:76–84PubMedCrossRef

Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T (1994) Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 51:849–859; discussion 844–863.PubMed

Pritchard JK, Donnelly P (2001) Case-control studies of association in structured or admixed populations. Theor Popul Biol 60:227–237PubMedCrossRef

Reyes GD, Esterling LE, Corona W, Ferraren D, Rollins DY, Padigaru M, Yoshikawa T, Monje VD, Detera-Wadleigh SD (2002) Map of candidate genes and STSs on 18p11.2, a bipolar disorder and schizophrenia susceptibility region. Mol Psychiatry 7:337–339PubMedCrossRef

Richards M, Iijima Y, Kondo H, Shizuno T, Hori H, Arima K, Saitoh O, Kunugi H (2006) Association study of the vesicular monoamine transporter 1 (VMAT1) gene with schizophrenia in a Japanese population. Behav Brain Funct 2:39PubMedCrossRef

Rojas K, Liang L, Johnson EI, Berrettini WH, Overhauser J (2000) Identification of candidate genes for psychiatric disorders on 18p11. Mol Psychiatry 5:389–395PubMedCrossRef

Saunders MA, Liang H, Li WH (2007) Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA 104:3300–3305PubMedCrossRef

Scarr E, Gray L, Keriakous D, Robinson PJ, Dean B (2006) Increased levels of SNAP–25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder. Bipolar Disord 8:133–143PubMedCrossRef

Seiden LS, Sabol KE, Ricaurte GA (1993) Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 33:639–676PubMedCrossRef

Skehel PA, Martin KC, Kandel ER, Bartsch D (1995) A VAMP-binding protein from Aplysia required for neurotransmitter release. Science 269:1580–1583PubMedCrossRef

Slattery DA, Hudson AL, Nutt DJ (2004) Invited review: the evolution of antidepressant mechanisms. Fundam Clin Pharmacol 18:1–21PubMedCrossRef

Spielman RS, Ewens WJ (1996) The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 59:983–989PubMed

Stine OC, Xu J, Koskela R, McMahon FJ, Gschwend M, Friddle C, Clark CD, McInnis MG, Simpson SG, Breschel TS et al (1995) Evidence for linkage of bipolar disorder to chromosome 18 with a parent-of-origin effect. Am J Hum Genet 57:1384–1394PubMed

Sullivan PF (2007) Spurious genetic associations. Biol Psychiatry 61:1121–1126PubMedCrossRef

The Welcome Trust Case Control Consortium (2007) Genome-wide association study of 14, 000 cases of seven common diseases and 3,000 shared controls. Nature 447:661–678CrossRef

Tsiouris SJ, Breschel TS, Xu J, McInnis MG, McMahon FJ (1996) Linkage disequilibrium analysis of G-olf alpha (GNAL) in bipolar affective disorder. Am J Med Genet 67:491–494PubMedCrossRef

Vawter MP, Thatcher L, Usen N, Hyde TM, Kleinman JE, Freed WJ (2002) Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Mol Psychiatry 7:571–578PubMedCrossRef

Washizuka S, Kakiuchi C, Mori K, Kunugi H, Tajima O, Akiyama T, Nanko S, Kato T (2003) Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 120:72–78CrossRef

Washizuka S, Iwamoto K, Kazuno AA, Kakiuchi C, Mori K, Kametani M, Yamada K, Kunugi H, Tajima O, Akiyama T, Nanko S, Yoshikawa T, Kato T (2004) Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder in Japanese and the National Institute of Mental Health pedigrees. Biol Psychiatry 56:483–489PubMedCrossRef

Weir ML, Klip A, Trimble WS (1998) Identification of a human homologue of the vesicle-associated membrane protein (VAMP)-associated protein of 33 kDa (VAP–33): a broadly expressed protein that binds to VAMP. Biochem J 333(Pt 2):247–251PubMed

Weir ML, Xie H, Klip A, Trimble WS (2001) VAP-A binds promiscuously to both v- and tSNAREs. Biochem Biophys Res Commun 286:616–621PubMedCrossRef

Weller AE, Dahl JP, Lohoff FW, Ferraro TN, Berrettini WH (2006) Analysis of variations in the NAPG gene on chromosome 18p11 in bipolar disorder. Psychiatr Genet 16:3–8PubMedCrossRef

Yoshikawa T, Turner G, Esterling LE, Sanders AR, Detera-Wadleigh SD (1997) A novel human myo-inositol monophosphatase gene, IMP.18p, maps to a susceptibility region for bipolar disorder. Mol Psychiatry 2:393–397PubMedCrossRef

Yoshikawa T, Padigaru M, Karkera JD, Sharma M, Berrettini WH, Esterling LE, Detera-Wadleigh SD (2000) Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2). Mol Psychiatry 5:165–171PubMedCrossRef

Titel: Association between polymorphisms in the vesicle-associated membrane protein-associated protein A (VAPA) gene on chromosome 18p and bipolar disorder
verfasst von: Falk W. Lohoff
Andrew E. Weller
Paul J. Bloch
Aleksandra H. Nall
Thomas N. Ferraro
Wade H. Berrettini
Publikationsdatum: 01.09.2008
Verlag: Springer Vienna
Erschienen in: Journal of Neural Transmission / Ausgabe 9/2008
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-008-0093-9

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2008

l-dopa modulates motor cortex excitability in Alzheimer’s disease patients

Downhill training upregulates mice hippocampal and striatal brain-derived neurotrophic factor levels

An association analysis of synapse-associated protein 97 (SAP97) gene in schizophrenia

Failure to confirm an association between Epsin 4 and schizophrenia in a Japanese population

Age-dependent changes in neuronal distribution of CacyBP/SIP: comparison to tubulin and the tau protein